Gainers
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares moved upwards by 17.3% to $4.2 during Thursday's after-market session. Today's trading volume for this security ended up closing at 285.6K shares, which is 424.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $9.5 million.
- Midatech Pharma (NASDAQ:MTP) stock moved upwards by 17.29% to $0.78. The market value of their outstanding shares is at $3.3 million.
- Nymox Pharmaceutical (NASDAQ:NYMX) stock moved upwards by 11.72% to $0.53. The market value of their outstanding shares is at $47.9 million.
- Rubius Therapeutics (NASDAQ:RUBY) stock moved upwards by 11.15% to $0.26. The market value of their outstanding shares is at $23.1 million.
- Ontrak (NASDAQ:OTRK) shares increased by 10.82% to $1.34. Today's trading volume for this security ended up closing at 1.6 million shares, which is 51.7 percent of its average volume over the last 100 days. The company's market cap stands at $36.2 million.
- Sientra (NASDAQ:SIEN) shares moved upwards by 8.07% to $0.23. The company's market cap stands at $23.1 million.
Losers
- Kala Pharmaceuticals (NASDAQ:KALA) shares decreased by 10.3% to $15.9 during Thursday's after-market session. The company's market cap stands at $25.3 million.
- AnPac Bio-Medical Science (NASDAQ:ANPC) shares fell 7.67% to $9.51. The market value of their outstanding shares is at $387.8 million.
- Fresh Tracks Therapeutics (NASDAQ:FRTX) shares decreased by 6.89% to $2.03. The market value of their outstanding shares is at $6.1 million.
- Infinity Pharmaceuticals (NASDAQ:INFI) stock fell 6.0% to $0.65. The market value of their outstanding shares is at $58.1 million.
- Synlogic (NASDAQ:SYBX) shares fell 5.01% to $0.95. Trading volume for this security closed at 933.6K, accounting for 579.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $66.9 million.
- Aprea Therapeutics (NASDAQ:APRE) shares decreased by 5.0% to $0.46. The company's market cap stands at $24.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.